Why Is Leap Therapeutics Down 9% In Pre-Market Trading?

Benzinga_recent_news10-07

Leap Therapeutics Inc. (NASDAQ:LPTX) is trading at $0.69 in pre-market, down 9.15% on Tuesday. Check out the current price of LPTX stock here. The Cambridge, Massachusetts-based biotechnology company ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2573395306?lang=en_US&edition=fundamental","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/10/07/Stockmarket-Online-Trading-Chart-Candles.jpeg?optimize=medium&dpr=2&auto=webp&width=240","is_english":true,"pubTime":"2025-10-07 16:55","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2573395306","market":"us","top_or_hot":-1,"title":"Why Is Leap Therapeutics Down 9% In Pre-Market Trading?","media":"Benzinga_recent_news","content":"<div>\n<p>Leap Therapeutics Inc. (NASDAQ:LPTX) is trading at $0.69 in pre-market, down 9.15% on Tuesday.\nCheck out the current price of LPTX stock here.\nThe Cambridge, Massachusetts-based biotechnology company ...</p>\n\n<a href=\"https://www.benzinga.com/markets/equities/25/10/48061531/why-is-leap-therapeutics-down-9-in-pre-market-trading\">Source Link</a>\n\n</div>\n","source":"benzinga_recent_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Is Leap Therapeutics Down 9% In Pre-Market Trading?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Is Leap Therapeutics Down 9% In Pre-Market Trading?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-10-07 16:55 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/markets/equities/25/10/48061531/why-is-leap-therapeutics-down-9-in-pre-market-trading><strong>Benzinga_recent_news</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Leap Therapeutics Inc. (NASDAQ:LPTX) is trading at $0.69 in pre-market, down 9.15% on Tuesday.\nCheck out the current price of LPTX stock here.\nThe Cambridge, Massachusetts-based biotechnology company ...</p>\n\n<a href=\"https://www.benzinga.com/markets/equities/25/10/48061531/why-is-leap-therapeutics-down-9-in-pre-market-trading\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LENZ","symbol_name":"Therapeutics","start_time":0,"source_url":"https://www.benzinga.com/markets/equities/25/10/48061531/why-is-leap-therapeutics-down-9-in-pre-market-trading","article_id":"2573395306","we_media_id":null,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/10/07/Stockmarket-Online-Trading-Chart-Candles.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/markets/equities/25/10/48061531/why-is-leap-therapeutics-down-9-in-pre-market-trading","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2573395306","pubTimestamp":1759827300,"columns":[],"sourceInfo":{"source_id":"benzinga_recent_news","name":"Benzinga"},"weMediaInfo":null,"summary":"Leap Therapeutics is trading lower in pre-market following a $58.9 million private placement led by Winklevoss Capital.","collect":0,"end_time":0,"defaultTopTitle":"benzinga.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"LENZ":"Therapeutics","BK4007":"制药","BK4539":"次新股","BK4505":"高瓴资本持仓","BK4563":"昨日强势股","BK4139":"生物科技"},"translate_title":"为什么Leap Therapeutics在盘前交易中下跌9%？","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LPTX":1,"LENZ":1.5},"content_text":"Leap Therapeutics Inc. (NASDAQ:LPTX) is trading at $0.69 in pre-market, down 9.15% on Tuesday.\nCheck out the current price of LPTX stock here.\nThe Cambridge, Massachusetts-based biotechnology company announced $58.88 million in cash commitments for a private investment in public equity offering led by Winklevoss Capital. \nAccording to an Oct. 6 press release, the deal involves 95,849,353 common shares or pre-funded warrants, along with warrants to purchase an additional 71,887,008 shares for $0.5335 each. The total combined price per unit is $0.61439.\nSee Also: Spruce Biosciences (SPRB) Stock Jumps 30% After Hours Following Red Hot Rally On Monday: Here’s Why\nLeap entered the agreement as part of its plan to launch a digital asset treasury strategy, with Winklevoss Capital providing both funding and strategic guidance. A portion of the capital will also support the development of its therapeutic programs, FL-501 and sirexatamab.\nThe latter recently completed a Phase 2 trial in colorectal cancer patients, with results set to be presented at the ESMO Congress 2025 on Oct. 19 in Berlin.\nLeap will also expand its board of directors to 12 members as part of the agreement. Winklevoss Capital will nominate two directors, one of whom will serve as board chair. \nThe private placement is expected to close on Wednesday, pending customary closing conditions.\nLeap reported a loss of $0.40 per share in its second quarter, compared with analyst estimates of a $0.29 loss. The company reported zero revenue, in line with estimates. The next earnings report is scheduled for Nov. 12.\nLeap Therapeutics has a yearly trading range between $0.22 and $4.79, a market capitalization of $31.86 million, and an average daily trading volume of 1.61 million shares. \nThe biotech has gained 163.34% over the past six months, despite a 73.48% decline since the start of the year.\nPrice Action: According to Benzinga Pro data, LPTX closed Monday at $0.76, marking a 43.15% increase for the day.\nBenzinga’s Edge Stock Rankings show that LPTX is experiencing short- and mid-term upward momentum, while undergoing long-term consolidation. See how its performance compares to other well-known stocks.\nRead Next:\nPhoto courtesy: Korot Yurii on Shutterstock.com\nDisclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2573395306","isCrawlerRequest":true}